Receiving a COVID-19 mRNA vaccine around the start of cancer immunotherapy nearly doubled survival in some patients. Scientists say it could mark the beginning of a new era in cancer treatment powered by mRNA technology. Credit: Shutterstock Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of beginning immunotherapy treatment lived considerably longer than those who were not vaccinated, according to new research. Scientists from the University of

Tag-uri: Coronavirus